West Hill Financial Advisors, Inc. Cytom X Therapeutics, Inc. Transaction History
West Hill Financial Advisors, Inc.
- $470 Million
- Q2 2025
A detailed history of West Hill Financial Advisors, Inc. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, West Hill Financial Advisors, Inc. holds 17,082 shares of CTMX stock, worth $40,142. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,082
Previous 17,082
-0.0%
Holding current value
$40,142
Previous $10,000
280.0%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTMX
# of Institutions
66Shares Held
44.1MCall Options Held
8.9KPut Options Held
47.9K-
Vanguard Group Inc Valley Forge, PA9.38MShares$22 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA6.72MShares$15.8 Million0.28% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$12.3 Million0.15% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$9.24 Million0.9% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$6.64 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $155M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...